Related Experiment Videos
[Pulmonary embolism--preventive measures with special reference to the cava filter]
1Departement für Innere Medizin, Universitätskliniken Basel.
Schweizerische Medizinische Wochenschrift
|October 28, 1989
Summary
Pulmonary embolism prevention includes deep vein thrombosis prophylaxis and recurrence prevention. Newer vena caval filters are safe and effective when heparin therapy fails or is contraindicated.
Area of Science:
- Cardiovascular Medicine
- Vascular Surgery
- Interventional Radiology
Context:
- Pulmonary embolism (PE) prevention involves managing deep vein thrombosis (DVT) and preventing PE recurrence.
- Heparin therapy is the primary secondary prevention strategy for PE.
- Alternative interventions are needed for patients with contraindications, complications, or treatment failure.
Purpose:
- To review indications and methods for inferior vena cava (IVC) interruption.
- To evaluate the safety and efficacy of modern vena caval filters.
- To compare literature findings with personal clinical experience.
Summary:
- Inferior vena cava filters are indicated for secondary prevention of PE in specific patient groups.
- Contemporary vena caval filters demonstrate ease of implantation and minimal disruption to IVC blood flow.
- These devices are effective in preventing recurrent PE, addressing prior concerns regarding their use.
Impact:
- Modern vena caval filters offer a viable and effective alternative to anticoagulation in select PE patients.
- Improved filter technology has reduced concerns about complications and blood flow disturbances.
- This supports earlier consideration of IVC filters in appropriate clinical scenarios.